Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth

Catheter Precision, Inc. (NYSE American: VTAK) today announced transformational balance sheet improvements through new institutional capital commitments supporting the Company’s next phase of growth.
Yahoo Finance

Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance

Fort Mill, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac ...
Yahoo Finance

Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split

FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the ...
Nasdaq

Catheter Precision, Inc. Completes Acquisition of PeriKard, LLC to Enhance Ventricular Therapeutic Market Offerings

Catheter Precision, Inc. has successfully completed the acquisition of PeriKard, LLC, which was announced previously and executed as an all-stock transaction. David Jenkins, the CEO of Catheter ...
Nasdaq

Catheter Precision, Inc. Addresses Increased Trading Activity in Common Stock

Catheter Precision, Inc., a medical device company focused on electrophysiology products, issued a press release on June 12, 2025, to address recent increases in trading activity of its common stock.
Blockonomi

Catheter Precision (VTAK) Stock Rockets 60% Following Fly Flyte Acquisition Agreement

Catheter Precision (VTAK) stock jumped 60% after revealing an $11.55M deal to purchase Fly Flyte and Ponderosa, expanding into aviation infrastructure.